Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mlynarski

Showing results (241-250 of 274) with videos related to

Pageof 28
Sort By:
Oncogene|January 29, 2022
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclaxKlaudyna Fidyt, Agata Pastorczak, Julia Cyran, et al.
Journal of Medical Genetics|December 13, 2012
Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DSDonna M McDonald-McGinn, Somayyeh Fahiminiya, Timothée Revil, et al.
European Journal of Medical Genetics|February 12, 2023
European standard clinical practice - Key issues for the medical care of individuals with familial leukemiaAlisa Förster, Claudia Davenport, Nicolas Duployez, et al.
Diabetes|April 4, 2014
GATA4 mutations are a cause of neonatal and childhood-onset diabetesCharles Shaw-Smith, Elisa De Franco, Hana Lango Allen, et al.
Diabetes Research and Clinical Practice|November 26, 2021
Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetesA Zmysłowska, P Jakiel, K Gadzalska, et al.
Science Advances|November 5, 2021
TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagyCarolina Alquezar, Kathleen M Schoch, Ethan G Geier, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of (2<i>R</i>,4<i>R</i>)-4-((<i>S</i>)-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat CancerScott N Mlynarski, Brian M Aquila, Susan Cantin, et al.
Molecular Oncology|March 13, 2019
Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemiaKlaudyna Fidyt, Agata Pastorczak, Agnieszka Goral, et al.
Nature Communications|November 14, 2018
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumorsManasi Ratnaparkhe, John K L Wong, Pei-Chi Wei, et al.
The Lancet. Haematology|June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemiaLiv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Pageof 28

Showing results (241-250 of 274) with videos related to

Sort By:
Pageof 28
Oncogene|January 29, 2022
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclaxKlaudyna Fidyt, Agata Pastorczak, Julia Cyran, et al.
Journal of Medical Genetics|December 13, 2012
Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DSDonna M McDonald-McGinn, Somayyeh Fahiminiya, Timothée Revil, et al.
European Journal of Medical Genetics|February 12, 2023
European standard clinical practice - Key issues for the medical care of individuals with familial leukemiaAlisa Förster, Claudia Davenport, Nicolas Duployez, et al.
Diabetes|April 4, 2014
GATA4 mutations are a cause of neonatal and childhood-onset diabetesCharles Shaw-Smith, Elisa De Franco, Hana Lango Allen, et al.
Diabetes Research and Clinical Practice|November 26, 2021
Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetesA Zmysłowska, P Jakiel, K Gadzalska, et al.
Science Advances|November 5, 2021
TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagyCarolina Alquezar, Kathleen M Schoch, Ethan G Geier, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of (2<i>R</i>,4<i>R</i>)-4-((<i>S</i>)-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat CancerScott N Mlynarski, Brian M Aquila, Susan Cantin, et al.
Molecular Oncology|March 13, 2019
Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemiaKlaudyna Fidyt, Agata Pastorczak, Agnieszka Goral, et al.
Nature Communications|November 14, 2018
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumorsManasi Ratnaparkhe, John K L Wong, Pei-Chi Wei, et al.
The Lancet. Haematology|June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemiaLiv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Pageof 28